SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biofield may double within 3 months!

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Lenis Warren who wrote (82)3/3/1997 1:30:00 AM
From: John Zwiener   of 120
 
Hi Lenis Warren, I don't know if this is cold fusion or not. On post #74, I described my concerns. None of the European research has been posted. What kind of approval was granted in Europe? Is it really for the "indication" for screening as a substitute for mammograms? What is meant by basing the algorthyms on clinical data? Did they change them around to get better results? If they did, then this is a retrospective study, and not a prospective double blind study anymore. What is their endpoint as to what is positive?

The first step here is to post the Europe study so it can be analysed. Also find out what kind of approval they got. I'll bet it's limited.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext